WELLS FARGO & COMPANY/MN
Position in CTXR — Citius Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in CTXR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$605
+$574 QoQ
Shares Held
1,000
+2400.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 43 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTXR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,774,320 across 417 Biotechnology names. CTXR ranks #369 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in CTXR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $605 | 1,000 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $31 | 40 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $49 | 40 | Shares | Defined | 2025-11-13 | |
| 2024-06-30 | $2,336 | 4,000 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $45,605 | 50,842 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $31,329 | 41,386 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $23,206 | 33,928 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $61,771 | 51,476 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $5,768 | 4,930 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,883 | 4,916 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,920 | 4,893 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,508 | 4,900 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $53,202 | 29,722 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $103,422 | 67,158 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,316,657 | 648,600 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,791 | 4,538 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,839 | 2,719 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,309 | 2,264 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,337 | 2,248 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $2,391 | 2,116 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $11,151 | 18,586 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||